Professor Samuel Gidding, MD

Professor, Geisinger Genomics Institute

Current:

Professor, Geisinger Genomics Institute, part time
Ongoing funded clinical/epidemiologic research: IMPACTFH, CARE-FH, and RISKFH (NIH); Innovative Cardiovascular Health Program (CDC)
Member Science Committee of the World Heart Federation and co-chair International FH
Consultant to Esperion for clinical trials of bempedoic acid in children

Prior positions:

Medical Director, FH Foundation: May 2018-December 2019

Cardiology Division Head, Nemours Cardiac Center, A.I. duPont Hospital for Children; Practiced Pediatric and Preventive Cardiology for the Nemours Cardiac Center for 18 years; became cardiology division head in January 2008: July 2000-June 2018

Interim Division Head, Pediatric Cardiology; Children’s Memorial Hospital, Chicago, IL
Associate Professor of Pediatrics and Preventive Medicine, Northwestern University Medical School
Sixteen years of experience in Chicago as a clinical and academic cardiologist including organization of several outreach clinics, introducing fetal echocardiography in the region (1986), organizing one of the first preventive cardiology clinics in the country (1987), participating in cardiac transplantation program (1990), served as interim division head for 4.5 years of my tenure there: July 1984-June 2000

Chairmanship positions:

American Heart Association Epidemiology and Lifestyle Spring Scientific Sessions Program Committee. American Heart Association Committee on Atherosclerosis in Youth, Illinois Coalition Against Tobacco, IIIrd International Conference on Atherosclerosis in Youth, Children’s Memorial Hospital IRB; Pediatric Lipidology Primer at ISA 2018

Past clinical interests included preventive cardiology, general pediatric cardiology, echocardiography, exercise, and heart failure/transplantation. Prior funded research includes co-investigator for the echocardiography reading centers of the TODAY and CARDIA studies and a study on cardiovascular risk in Down syndrome. Was a co-investigator of the DISC study and collaborated with the Bogalusa Heart Study. Was principal investigator of a randomized trial for fish oil treatment of moderate hypertriglyceridemia in adolescents. Participated in many local studies on congenital heart disease, on the cardiovascular morbidity of obesity, and early imaging of atherosclerosis. Helped design the DO-IT trial, a statin intervention trial in adolescents funded by the Pediatric Heart Network (NHLBI) and was a site co-investigator for the AMGEN pediatric PCSK9 inhibitor trial. Past member of the CHSA study section.

Career accomplishments:

Has published over 400 scientific papers including over 200 scientific articles, 35 guidelines and consensus statements, 40 review articles and 40 editorials.

Founded PEDAL, a consortium dedicated to prevention of adult onset lipid related diseases beginning in youth. Was a member of the ACC/AHA task force on clinical practice guidelines and participated in the development of new adult and pediatric blood pressure guidelines. Was a member of the scientific advisory board and publication committees of the FH Foundation and FH Europe. Has previously worked on guidelines/scientific statements on familial hypercholesterolemia, hypertension, tobacco, obesity, nutrition, diabetes, and congenital heart disease for AHA, ACC, AAP, NHLBI, WHO, CDC, EAS, NLA, and ADA.

Training:

UMDNJ-RWJ (Medical School) 1974-78, SUNY-Upstate (Pediatrics) 1978-81, University of Michigan (Cardiology) 1981-84